BME
BlackRock Health Sciences Trust
1W: -2.7%
1M: -7.9%
3M: -4.0%
YTD: -5.0%
1Y: +5.2%
3Y: +17.4%
5Y: +12.2%
$38.67
-0.43 (-1.10%)
After Hours: $40.50 (+1.83, +4.75%)
ETF-Level Metrics
AUM$500M
Holdings118
Top 10 Wt48.6%
Beta0.60
% Profitable23%
Coverage99%
Portfolio Valuation
P/E2008.8
P/B486.2
P/S222.4
EV/EBITDA17.8
P/FCF2333.8
PEG81.63
Profitability & Returns
Gross Margin47.6%
Net Margin11.0%
ROE25.1%
ROA8.9%
ROIC18.4%
Div Yield1.26%
Leverage & Liquidity
Debt/Equity0.79
Debt/Assets0.28
Net Debt/EBITDA1.2x
Interest Cov11.0x
Current Ratio1.34
Quick Ratio1.04
Growth (YoY)
Revenue+17.8%
Net Income+37.0%
EPS+48.0%
FCF+46.8%
EBITDA+40.6%
Rev CAGR 3Y+15.6%
Quality Scores
Piotroski F6.6
Altman Z8.21
IS Quality72.5
IS Overall59.7
IS Value41.5
Median P/E12.1
Sector Breakdown
4 sectors| Sector | # Holdings | Total Weight % | Avg P/E |
|---|---|---|---|
| Healthcare | 116 | 98.6% | 0.9 |
| Other | 166 | 1.0% | — |
| Consumer Defensive | 1 | 0.5% | 48.7 |
| Financial Services | 1 | 0.1% | -2.0 |
Smart Money Overlap
6 holdings with signals| Symbol | Company | Weight % | Signals | Badge | Insider Buys | Congress | Since Signal |
|---|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | 8.22% | 4 | Bullish | 12 | 2 | -2.7% |
| MRK | Merck & Co., Inc. | 1.43% | 4 | Bullish | 11 | 2 | -3.5% |
| WAT | Waters Corporation | 0.60% | 4 | Bullish | 24 | 1 | -1.1% |
| PFE | Pfizer Inc. | 0.52% | 4 | Bullish | 11 | 1 | +1.5% |
| CVS | CVS Health Corporation | 0.47% | 4 | Bullish | 9 | 2 | -0.5% |
| ILMN | Illumina, Inc. | 0.25% | 4 | Bullish | 12 | 1 | -3.0% |
Showing 50 of 284 holdings
· Page 1 of 6
| # | Name | Ticker | Weight % ▼ | Mkt Value | Shares | P/E | Mkt Cap | Sector |
|---|---|---|---|---|---|---|---|---|
| 1 | Johnson & Johnson | JNJ | 8.22% | $42.8M | 230,823 | 21.3 | $567.2B | Healthcare |
| 2 | Eli Lilly & Co | LLY | 7.81% | $40.6M | 53,254 | 39.4 | $856.6B | Healthcare |
| 3 | Abbott Laboratories | ABT.SW | 5.96% | $31.0M | 231,527 | 28.3 | $146.8B | Healthcare |
| 4 | AbbVie Inc | ABBV | 4.74% | $24.6M | 106,461 | 86.4 | $362.6B | Healthcare |
| 5 | UnitedHealth Group Inc | UNH.BA | 4.20% | $21.9M | 63,340 | 20.8 | $368.5T | Healthcare |
| 6 | Boston Scientific Corp | BSX | 4.05% | $21.1M | 215,674 | 35.6 | $103.1B | Healthcare |
| 7 | Thermo Fisher Scientific Inc | TMO | 3.50% | $18.2M | 37,523 | 26.6 | $176.2B | Healthcare |
| 8 | Stryker Corp | SYK | 3.47% | $18.0M | 48,820 | 39.6 | $128.5B | Healthcare |
| 9 | Medtronic PLC | 2M6.DE | 3.44% | $17.9M | 187,946 | 23.9 | $96.2B | Healthcare |
| 10 | Amgen Inc | AMGN | 3.24% | $16.9M | 59,717 | 24.3 | $187.5B | Healthcare |
| 11 | Edwards Lifesciences Corp | EW | 3.07% | $16.0M | 205,137 | 44.7 | $47.9B | Healthcare |
| 12 | Alnylam Pharmaceuticals Inc | ALNY | 2.73% | $14.2M | 31,166 | 131.6 | $41.4B | Healthcare |
| 13 | Intuitive Surgical Inc | ISRG | 2.62% | $13.6M | 30,454 | 59.4 | $169.7B | Healthcare |
| 14 | Gilead Sciences Inc | GILD.SW | 1.92% | $10.0M | 89,782 | — | $142.5B | Healthcare |
| 15 | McKesson Corp | MCK | 1.75% | $9.1M | 11,805 | 25.1 | $109.3B | Healthcare |
| 16 | Danaher Corp | DHR | 1.69% | $8.8M | 44,278 | 37.1 | $133.9B | Healthcare |
| 17 | Cencora Inc | ABC | 1.60% | $8.3M | 26,637 | 39.1 | $36.1B | Healthcare |
| 18 | Insmed Inc | INSM | 1.45% | $7.6M | 52,511 | -22.8 | $29.3B | Healthcare |
| 19 | Merck & Co Inc | MRK | 1.43% | $7.4M | 88,682 | 15.6 | $282.3B | Healthcare |
| 20 | Becton Dickinson & Co | BDX | 1.39% | $7.2M | 38,538 | 25.0 | $55.8B | Healthcare |
| 21 | BlackRock Liquidity Funds Private | — | 1.37% | $7.1M | 7,130,620 | — | — | — |
| 22 | Labcorp Holdings Inc | LH | 1.13% | $5.9M | 20,462 | 24.8 | $21.8B | Healthcare |
| 23 | Rhythm Pharmaceuticals Inc | RYTM | 1.07% | $5.6M | 55,078 | -29.8 | $6.0B | Healthcare |
| 24 | HCA Healthcare Inc | HCA | 1.03% | $5.4M | 12,565 | 16.8 | $110.4B | Healthcare |
| 25 | Vertex Pharmaceuticals Inc | VRTX | 0.97% | $5.0M | 12,835 | 29.2 | $115.3B | Healthcare |
| 26 | Regeneron Pharmaceuticals Inc | REGN | 0.96% | $5.0M | 8,927 | 16.7 | $76.1B | Healthcare |
| 27 | AstraZeneca PLC | ZEG.DE | 0.96% | $3.7M | 32,707 | 27.7 | $249.2B | Healthcare |
| 28 | Teva Pharmaceutical Industries Ltd | TEVA | 0.94% | $4.9M | 243,163 | 24.0 | $33.5B | Healthcare |
| 29 | Agilent Technologies Inc | A | 0.91% | $4.7M | 37,005 | 24.4 | $31.5B | Healthcare |
| 30 | Quest Diagnostics Inc | DGX | 0.89% | $4.6M | 24,219 | 21.8 | $21.7B | Healthcare |
| 31 | IDEXX Laboratories Inc | IDXX | 0.85% | $4.4M | 6,922 | 43.6 | $46.1B | Healthcare |
| 32 | Bristol-Myers Squibb Co | BMY | 0.85% | $4.4M | 97,755 | 16.6 | $117.1B | Healthcare |
| 33 | Argenx SE | ARGX | 0.82% | $4.3M | 5,763 | 36.9 | $41.1B | Healthcare |
| 34 | Biogen Inc | BIIB | 0.79% | $4.1M | 29,185 | 20.6 | $26.6B | Healthcare |
| 35 | Waters Corp | WAT | 0.60% | $3.1M | 10,495 | 27.7 | $17.8B | Healthcare |
| 36 | IQVIA Holdings Inc | IQV | 0.59% | $3.1M | 16,167 | 20.7 | $28.2B | Healthcare |
| 37 | Penumbra Inc | PEN | 0.58% | $3.0M | 11,896 | 74.1 | $13.2B | Healthcare |
| 38 | UCB SA | UCB.BR | 0.54% | $2.4M | 10,073 | 30.1 | $46.9B | Healthcare |
| 39 | Incyte Corp | INCY | 0.54% | $2.8M | 33,103 | 13.9 | $18.1B | Healthcare |
| 40 | Pfizer Inc | PFE | 0.52% | $2.7M | 106,328 | 19.7 | $153.4B | Healthcare |
| 41 | Exact Sciences Corp | EXAS | 0.52% | $2.7M | 49,509 | -95.7 | $20.0B | Healthcare |
| 42 | Cigna Group/The | CI | 0.52% | $2.7M | 9,313 | 11.7 | $70.2B | Healthcare |
| 43 | West Pharmaceutical Services Inc | WST | 0.51% | $2.7M | 10,207 | 34.7 | $17.1B | Healthcare |
| 44 | Veeva Systems Inc | VEEV | 0.51% | $2.7M | 8,920 | 33.3 | $30.3B | Healthcare |
| 45 | Dexcom Inc | DXCM | 0.49% | $2.6M | 38,114 | 31.0 | $26.1B | Healthcare |
| 46 | Nuvalent Inc | NUVL | 0.49% | $2.5M | 29,333 | -16.7 | $6.9B | Healthcare |
| 47 | Elevance Health Inc | ANTM | 0.49% | $2.5M | 7,850 | 11.4 | $114.6B | Healthcare |
| 48 | Insulet Corp | PODD | 0.47% | $2.5M | 8,004 | 64.7 | $16.0B | Healthcare |
| 49 | CVS Health Corp | CVS | 0.47% | $2.5M | 32,565 | 51.3 | $90.9B | Healthcare |
| 50 | Galderma Group AG | GALD.SW | 0.46% | $1.9M | 13,599 | 48.7 | $33.3B | Consumer Defensive |